Back to today’s briefing

Story perspectives

FDA Approves First Non-Opioid Painkiller in 20 Years

2/2/2025

47 7

Summary

Story summary

In a groundbreaking move, the FDA has greenlit Journavx (suzetrigine), marking the arrival of the first non-opioid painkiller in two decades. Developed by Vertex Pharmaceuticals, this innovative oral medication targets peripheral nerves to block pain signals, providing a safer option that could help combat the opioid crisis while enhancing pain relief for acute conditions.

1 of 1

Story summary

In a groundbreaking move, the FDA has greenlit Journavx (suzetrigine), marking the arrival of the first non-opioid painkiller in two decades. Developed by Vertex Pharmaceuticals, this innovative oral medication targets peripheral nerves to block pain signals, providing a safer option that could help combat the opioid crisis while enhancing pain relief for acute conditions.